Table 3.

Comparison of Data from the 1997, 2000, and 2002 Addressing Tobacco in Managed Care Surveys, United States

	1997 (N = 323) (% Yes)	2000 (N = 85) (% Yes)	2002 (N = 152) (% Yes)	P a
Plan provides full coverage for:
Any pharmacotherapy for smoking cessation	25.0	59.2	88.8	<.001
Zyban	17.6	37.2	41.1	.57
Any over-the-counter NRTb	6.6	14.9	8.6	.004
NRT only with program enrollment	25.0	26.0	10.8	.004
Plan provides full coverage for:
Telephone counseling	32.8	36.8	51.7	.04
Face-to-face counseling	26.6	23.6	41.1	.01
Group counseling or classes	35.7	37.0	15.9	<.001
Self-help materials	54.1	56.6	25.8	<.001
Plan provides full coverage for any behavioral or pharmacotherapy	75.0	94.4	98.0	.28
Plan requires providers to:
Ask new patients about smoking status	NAc	74.1	61.2	.02
Include smoking status as a vital sign (i.e., ask about and document status at every visit)	NA	43.5	54.3	.28
Strongly advise all patients who smoke to quit	NA	68.3	44.1	.02
Refer smokers to intensive treatment as appropriate	NA	24.7	33.6	.33
Arrange for follow-up with patients trying to quit smoking	NA	36.5	30.3	.15
Plan able to identify individual members who smoke	14.9	27.1	71.7	<.001
Plan has a specific strategy to address smoking cessation during:
Adolescence	17.6	24.2	28.9	.46
Pregnancy	45.0	59.0	56.6	.72
Postpartum visits (relapse prevention)	13.6	30.5	46.7	.02
Pediatric visits (secondhand smoke)	15.8	17.3	28.3	.06
Post-myocardial infarction	21.7	27.2	46.7	.004
Treatment for chronic illness	22.6	31.3	52.0	.002
Plan funds a full- or part-time tobacco control program staff position	7.7	23.5	19.1	.15

^a Boldface indicates a significant difference.

^bNRT indicates nicotine replacement therapy.

^cNA indicates data not available because question was not included in 1997 ATMC survey.